Cargando…

Sub-Classification of Cirrhosis Affects Surgical Outcomes for Early Hepatocellular Carcinoma Independent of Portal Hypertension

Severity of liver cirrhosis is distinct from clinical portal hypertension because there exist different degrees of liver cirrhosis in hepatocellular carcinoma (HCC) patients without significant clinical portal hypertension. Whether severity of cirrhosis affects surgical outcomes for HCC patients in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Er-lei, Li, Jiang, Li, Jian, Wang, Wen-qiang, Gu, Jin, Huang, Zhi-yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173036/ https://www.ncbi.nlm.nih.gov/pubmed/34094970 http://dx.doi.org/10.3389/fonc.2021.671313

Ejemplares similares

Effect of Severity of Liver Cirrhosis on Surgical Outcomes of Hepatocellular Carcinoma After Liver Resection and Microwave Coagulation
por: Li, Jiang, et al.
Publicado: (2021)

Hepatic Arterial Vasodilation Is Independent of Portal Hypertension in Early Stages of Cirrhosis
por: Moeller, Miriam, et al.
Publicado: (2015)

The kidney in cirrhosis with portal hypertension
por: Olteanu, D, et al.
Publicado: (2010)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Revisiting Surgical Strategies for Hepatocellular Carcinoma With Microvascular Invasion
por: Zhang, Er-lei, et al.
Publicado: (2021)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Advances and challenges in cirrhosis and portal hypertension
por: Berzigotti, Annalisa
Publicado: (2017)

Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study
por: Wang, Wen-qiang, et al.
Publicado: (2022)

Thermal ablation as an alternative to liver transplantation for hepatocellular carcinoma with clinically significant portal hypertension: propensity score matching study
por: Long, Yinglin, et al.
Publicado: (2023)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Extrapulmonary Sarcoidosis Manifested as Cirrhosis with Portal Hypertension
por: Kothakota, Sunil Raviraj, et al.
Publicado: (2021)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
por: Luo, Fangzhou, et al.
Publicado: (2021)

A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
por: Fiordaliso, Michele, et al.
Publicado: (2023)

Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis
por: Li, Tong, et al.
Publicado: (2016)

Portal Hypertensive Polyps as Gastroscopic Finding in Liver Cirrhosis
por: Topal, Firdevs, et al.
Publicado: (2020)

Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis
por: Maruyama, Hitoshi, et al.
Publicado: (2022)

Pulmonary hypertension in patients with hepatic cirrhosis and portal hypertension. An echographic study
por: GURGHEAN, ADRIANA V., et al.
Publicado: (2017)

Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol
por: Wang, Kang, et al.
Publicado: (2022)

Impact of clinically significant portal hypertension on surgical outcomes for hepatocellular carcinoma in patients with compensated liver cirrhosis: a propensity score matching analysis
por: Jang, Chul Woo, et al.
Publicado: (2016)

Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension
por: Yao, Hongjuan, et al.
Publicado: (2020)

The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis
por: Chen, Sheng, et al.
Publicado: (2015)

Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization
por: He, Chengjian, et al.
Publicado: (2022)

Future therapy of portal hypertension in liver cirrhosis – a guess
por: Sauerbruch, Tilman, et al.
Publicado: (2014)

Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension
por: Maruyama, Hitoshi, et al.
Publicado: (2015)

Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis
por: Segarra, Gloria, et al.
Publicado: (2016)

Portal Hypertensive Polyposis in Advanced Liver Cirrhosis: The Unknown Entity?
por: Kara, David, et al.
Publicado: (2018)

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
por: Herath, Chandana B., et al.
Publicado: (2022)

Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy
por: Liang, Bin-Yong, et al.
Publicado: (2022)

The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus
por: Yeh, Shyh-An, et al.
Publicado: (2015)

Emricasan (IDN‐6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
por: Garcia‐Tsao, Guadalupe, et al.
Publicado: (2018)

Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience
por: Chen, Yun, et al.
Publicado: (2019)

Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world
por: Feng, Jin-Kai, et al.
Publicado: (2022)

Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report
por: Wu, Xuwei, et al.
Publicado: (2023)

Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension
por: Zhong, Jian-Hong, et al.
Publicado: (2014)

Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis
por: Wang, Le, et al.
Publicado: (2017)

Endovascular brachytherapy with iodine-125 seed strand for extensive portal vein tumor thrombus in patients with hepatocellular carcinoma
por: Tan, Zhongbao, et al.
Publicado: (2023)

Results of Surgical Treatment (Modified Sugiura-Futagawa Operation) of Portal Hypertension Associated to Complete Splenomesoportal Thrombosis and Cirrhosis
por: Mercado, Miguel Angel, et al.
Publicado: (1999)

Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification
por: Xu, Jiang-feng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_erlm39pbeqf65sqd2gptut7lg3